These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 16125114)

  • 1. Calpains in muscle wasting.
    Bartoli M; Richard I
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2115-33. PubMed ID: 16125114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-dependent proteolytic system and muscle dysfunctions: a possible role of calpains in sarcopenia.
    Dargelos E; Poussard S; Brulé C; Daury L; Cottin P
    Biochimie; 2008 Feb; 90(2):359-68. PubMed ID: 17881114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca(2+)-dependent proteolysis in muscle wasting.
    Costelli P; Reffo P; Penna F; Autelli R; Bonelli G; Baccino FM
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2134-46. PubMed ID: 15893952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle.
    Murphy RM; Verburg E; Lamb GD
    J Physiol; 2006 Oct; 576(Pt 2):595-612. PubMed ID: 16857710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3.
    Garnham CP; Hanna RA; Chou JS; Low KE; Gourlay K; Campbell RL; Beckmann JS; Davies PL
    Biochemistry; 2009 Apr; 48(15):3457-67. PubMed ID: 19226146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain-related diseases.
    Branca D
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1098-104. PubMed ID: 15336956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic study of calpain interacting proteins during skeletal muscle aging.
    Brulé C; Dargelos E; Diallo R; Listrat A; Béchet D; Cottin P; Poussard S
    Biochimie; 2010 Dec; 92(12):1923-33. PubMed ID: 20850499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
    Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
    Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpains, skeletal muscle function and exercise.
    Murphy RM
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):385-91. PubMed ID: 19793101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the research of the relationship between calpains and post-burn skeletal muscle wasting].
    Ma L; Chai JK
    Zhonghua Shao Shang Za Zhi; 2013 Jun; 29(3):304-7. PubMed ID: 24059960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpains and disease.
    Zatz M; Starling A
    N Engl J Med; 2005 Jun; 352(23):2413-23. PubMed ID: 15944426
    [No Abstract]   [Full Text] [Related]  

  • 12. Calpain 3: a key regulator of the sarcomere?
    Duguez S; Bartoli M; Richard I
    FEBS J; 2006 Aug; 273(15):3427-36. PubMed ID: 16884488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
    Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
    Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain 3 Expression Pattern during Gastrocnemius Muscle Atrophy and Regeneration Following Sciatic Nerve Injury in Rats.
    Wu R; Yan Y; Yao J; Liu Y; Zhao J; Liu M
    Int J Mol Sci; 2015 Nov; 16(11):26927-35. PubMed ID: 26569227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3.
    Jenne DE; Kley RA; Vorgerd M; Schröder JM; Weis J; Reimann H; Albrecht B; Nürnberg P; Thiele H; Müller CR; Meng G; Witt CC; Labeit S
    Biol Chem; 2005 Jan; 386(1):61-7. PubMed ID: 15843148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.
    Gailly P; De Backer F; Van Schoor M; Gillis JM
    J Physiol; 2007 Aug; 582(Pt 3):1261-75. PubMed ID: 17510188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofibrillar protein turnover: the proteasome and the calpains.
    Goll DE; Neti G; Mares SW; Thompson VF
    J Anim Sci; 2008 Apr; 86(14 Suppl):E19-35. PubMed ID: 17709792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption.
    Fougerousse F; Gonin P; Durand M; Richard I; Raymackers JM
    Muscle Nerve; 2003 May; 27(5):616-23. PubMed ID: 12707983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro.
    Kramerova I; Kudryashova E; Tidball JG; Spencer MJ
    Hum Mol Genet; 2004 Jul; 13(13):1373-88. PubMed ID: 15138196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.
    Bartoli M; Roudaut C; Martin S; Fougerousse F; Suel L; Poupiot J; Gicquel E; Noulet F; Danos O; Richard I
    Mol Ther; 2006 Feb; 13(2):250-9. PubMed ID: 16290124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.